Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02080442
Other study ID # 13-o11-WP
Secondary ID
Status Completed
Phase N/A
First received March 3, 2014
Last updated March 4, 2014
Start date May 2013
Est. completion date February 2014

Study information

Verified date March 2014
Source West Park Healthcare Centre
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

The study will involve direct knowledge translation of a laboratory-based study of balance training for patients with COPD, first to the investigators PR program and then, after disseminating the results, this approach could be used to impact on clinical practice in any PR program.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date February 2014
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Diagnosis of COPD

- Self-report of decline in balance or fall in the last 5 years or a recent near fall

- Smoking history greater than 10 pack years

- Are able to provide written informed consent.

Exclusion Criteria:

- An inability to communicate because of language skills, hearing or cognitive impairment

- Evidence of a neurological or musculoskeletal condition that severely limits mobility and postural control (e.g., cerebrovascular accident, advanced Parkinson's disease, amputation).

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Other:
Balance training
Training will consist of 30 minute sessions 2-3 times/week for a total of 18-24 sessions, in keeping with best practice guidelines for older adults.12 Sessions will be supervised by physical therapists, using a circuit training approach with different stations designed to target specific areas of impairment. Participants will work through stations in a group setting; however, will receive individualized exercise prescription regarding level of difficulty and exercise progression.

Locations

Country Name City State
Canada West Park Healthcare Center Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Samantha Harrison Ontario Lung Association

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Balance training progression: the training prescription and progression will be recorded at 6 weeks No
Other Therapists' and the participants' satisfaction Patients completed a questionnaire following completion of the balance training which took place thrice weekly for a period of 6 weeks.
The focus group was conducted at the end of study recruitment.
at 6 weeks No
Other Safety: any adverse events associated with balance training will be recorded at 6 weeks Yes
Other Applicability and adherence at 6 weeks No
Other The Six-Minute Walk Test (6MWT) The 6MWT was assessed by the physiotherapists responsible for delivering the PR program. The PR programs runs over 6 weeks. at 6 weeks No
Primary Berg Balance Scale (BBS) The BBS was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks. at 6 weeks No
Primary Timed Up and Go (TUG): The TUG was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks. at 6 weeks No
Secondary The Balance Evaluation Systems Test (BESTest) The BESTest was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks. at 6 weeks No
Secondary Activity-specific Balance Confidence (ABC) Scale The ABC scale was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks. at 6 weeks No
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy